KIF21B — Kinesin Family Member 21B

KIF21B — Kinesin Family Member 21B

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KIF21B — Kinesin Family Member 21B</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">Motor (Head) Domain</td>
<td>N-terminal (1-350 aa)</td>
</tr>
<tr>
<td class="label">Coiled-coil Regions</td>
<td>Middle (350-1200 aa)</td>
</tr>
<tr>
<td class="label">Tail Domain</td>
<td>C-terminal (1200-1756 aa)</td>
</tr>
<tr>
<td class="label">Phenotype</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Intellectual Disability</td>
<td>Global cognitive impairment, developmental delay</td>
</tr>
<tr>
<td class="label">Cortical Malformations</td>
<td>Polymicrogyria, lissencephaly</td>
</tr>
<tr>
<td class="label">Epilepsy</td>
<td>Various seizure types</td>
</tr>
<tr>
<td class="label">Speech Delay</td>
<td>Expressive language deficits</td>
</tr>
<tr>
<td class="label">Motor Delay</td>
<td>Delayed milestone achievement</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Transport Enhancers</td>
<td>Small molecules to boost motor processivity</td>
</tr>
<tr>
<td class="label">Microtubule Stabilizers</td>
<td>Promote stable microtubule tracks</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>Viral vector delivery of wild-type KIF21B</td>
</tr>
<tr>
<td class="label">Antisense Oligonucleo

KIF21B — Kinesin Family Member 21B

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KIF21B — Kinesin Family Member 21B</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">Motor (Head) Domain</td>
<td>N-terminal (1-350 aa)</td>
</tr>
<tr>
<td class="label">Coiled-coil Regions</td>
<td>Middle (350-1200 aa)</td>
</tr>
<tr>
<td class="label">Tail Domain</td>
<td>C-terminal (1200-1756 aa)</td>
</tr>
<tr>
<td class="label">Phenotype</td>
<td>Description</td>
</tr>
<tr>
<td class="label">Intellectual Disability</td>
<td>Global cognitive impairment, developmental delay</td>
</tr>
<tr>
<td class="label">Cortical Malformations</td>
<td>Polymicrogyria, lissencephaly</td>
</tr>
<tr>
<td class="label">Epilepsy</td>
<td>Various seizure types</td>
</tr>
<tr>
<td class="label">Speech Delay</td>
<td>Expressive language deficits</td>
</tr>
<tr>
<td class="label">Motor Delay</td>
<td>Delayed milestone achievement</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Strategy</td>
</tr>
<tr>
<td class="label">Transport Enhancers</td>
<td>Small molecules to boost motor processivity</td>
</tr>
<tr>
<td class="label">Microtubule Stabilizers</td>
<td>Promote stable microtubule tracks</td>
</tr>
<tr>
<td class="label">Gene Therapy</td>
<td>Viral vector delivery of wild-type KIF21B</td>
</tr>
<tr>
<td class="label">Antisense Oligonucleotides</td>
<td>Reduce toxic mutant expression</td>
</tr>
<tr>
<td class="label">Year</td>
<td>Finding</td>
</tr>
<tr>
<td class="label">2011</td>
<td>KIF21B motor domain localization characterized</td>
</tr>
<tr>
<td class="label">2014</td>
<td>Role in neuronal migration established</td>
</tr>
<tr>
<td class="label">2016</td>
<td>Mutations linked to neurodevelopmental disorders</td>
</tr>
<tr>
<td class="label">2018</td>
<td>KIF21B in dendritic development and plasticity</td>
</tr>
<tr>
<td class="label">2018</td>
<td>Association with AD risk identified</td>
</tr>
<tr>
<td class="label">2019</td>
<td>KIF21B in spine formation and memory</td>
</tr>
<tr>
<td class="label">2020</td>
<td>KIF21B as MS susceptibility locus</td>
</tr>
<tr>
<td class="label">2021</td>
<td>KIF21B regulates tau phosphorylation</td>
</tr>
<tr>
<td class="label">2022</td>
<td>KIF21B in synaptic signaling transport</td>
</tr>
<tr>
<td class="label">Species</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">Human</td>
<td>KIF21B</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>Kif21b</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>kif21b</td>
</tr>
<tr>
<td class="label">Drosophila</td>
<td>Unc-104</td>
</tr>
<tr>
<td class="label">C. elegans</td>
<td>Unknown</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

KIF21B (Kinesin Family Member 21B) is a plus-end-directed motor protein belonging to the kinesin family that plays critical roles in neuronal development, intracellular transport, and synaptic function. Located on chromosome 1p31.3, KIF21B encodes a protein involved in the transport of cargo along microtubules, facilitating vesicular trafficking, organelle positioning, and signal transduction within neurons[@baker2011]. The protein is primarily expressed in the central nervous system, with particularly high levels in the cerebral cortex, hippocampus, and cerebellum, where it contributes to dendritic development, axonal guidance, and synaptic plasticity[@mars2014].

KIF21B has emerged as a significant gene in neurodevelopmental and neurodegenerative disorders. Mutations in KIF21B have been linked to intellectual disability, cortical malformations, and epilepsy, while alterations in KIF21B expression have been associated with increased risk for Alzheimer's disease, multiple sclerosis, and other neurological conditions[@hu2016][@abou2020]. The protein's role in microtubule dynamics and axonal transport positions it as a critical mediator of neuronal health and a potential therapeutic target.

Gene and Protein Structure

Genomic Organization

The KIF21B gene (NCBI Gene ID: 22873; Ensembl ID: ENSG00000145794; OMIM: 609783; UniProt: Q9Y4G1) spans approximately 45 kb on the minus strand of chromosome 1p31.3. The gene consists of 38 exons encoding a protein of 1,756 amino acids with a molecular weight of approximately 190 kDa[@baker2011]. The genomic region contains several conserved domains critical for motor function and cargo binding.

Protein Domain Architecture

KIF21B possesses the characteristic kinesin motor domain structure:

The motor domain contains conserved motifs for microtubule binding and ATP hydrolysis, while the tail domain mediates interactions with various cargo adaptor proteins including KIF21B-specific binding partners[@mueller2018].

Expression Pattern

Brain Region Specificity

KIF21B exhibits regional specificity within the central nervous system:

• Cerebral Cortex: High expression in layer 5 pyramidal neurons and interneurons[@mars2014]
• Hippocampus: Prominent in CA1 pyramidal cells and dentate gyrus granule cells[@wen2019]
• Cerebellum: Expressed in Purkinje cells and granule cells[@lipka2016]
• Basal Ganglia: Present in striatal medium spiny neurons[@deshmukh2013]
• Brainstem: Detected in various brainstem nuclei

Cellular Localization

Within neurons, KIF21B localizes to:

• Dendrites: Concentrated in dendritic shafts and spines[@mueller2018]
• Axon Initial Segment: Involved in axon specification[@gao2015]
• Growth Cones: Regulates axonal pathfinding[@mars2014]
• Synaptic Terminals: Modulates neurotransmitter release[@deshmukh2013]

Normal Physiological Functions

Microtubule-Based Transport

KIF21B functions as a plus-end-directed motor protein, moving cargo toward the distal ends of neurons. Unlike other kinesins, KIF21B exhibits unique transport properties:

Vesicular Trafficking: KIF21B transports synaptic vesicle precursors, endosomes, and Golgi-derived vesicles along microtubules within dendrites and axons[@yokota2016]. This transport is essential for maintaining synaptic homeostasis and neuronal polarity.

Organelle Positioning: The motor protein participates in positioning organelles including mitochondria, endosomes, and lysosomes within neuronal processes[@gao2015]. Proper organelle distribution is critical for energy metabolism, signaling, and debris clearance.

Signal Transduction: KIF21B facilitates the transport of signaling molecules including receptor complexes, second messengers, and transcription factors[@zhao2022]. This enables rapid communication between synaptic compartments and the cell body.

Neuronal Development

During development, KIF21B plays essential roles:

Neuronal Migration: KIF21B regulates the radial migration of cortical neurons by controlling microtubule dynamics and nuclear positioning[@mars2014]. The protein interacts with the dynein complex and microtubule-associated proteins to facilitate nucleokinesis.

Axon Guidance: In growth cones, KIF21B modulates microtubule polymerization and sliding to enable axon pathfinding[@homma2020]. The motor protein responds to guidance cues including netrin, slits, and semaphorins.

Dendrite Morphogenesis: KIF21B contributes to dendritic branching and arborization through the transport of branching-relevant cargo and regulation of microtubule organization[@wen2019].

Synaptic Function

At synapses, KIF21B regulates:

Synaptic Vesicle Trafficking: KIF21B transports synaptic vesicle precursors from the soma to presynaptic terminals[@deshmukh2013]. This ensures adequate vesicle pools for neurotransmitter release.

Postsynaptic Receptor Trafficking: The motor protein mediates the delivery and removal of AMPA and NMDA receptors at dendritic spines[@matsuda2019], affecting synaptic plasticity and long-term potentiation.

Dendritic Spine Dynamics: KIF21B influences spine formation, maintenance, and morphological plasticity through transport of actin regulators and scaffolding proteins[@wen2019].

Role in Neurodegenerative Diseases

Alzheimer's Disease

KIF21B has been implicated in multiple aspects of Alzheimer's disease pathogenesis:

Axonal Transport Defects: In AD brains, KIF21B expression is altered, leading to impaired axonal transport of APP and its cleavage products[@shin2018]. This contributes to the accumulation of amyloid-beta in dystrophic neurites.

Tau Pathology: KIF21B interacts with tau protein and regulates its phosphorylation state[@liu2021]. Hyperphosphorylated tau disrupts KIF21B-mediated transport, creating a feedforward loop of pathology.

Synaptic Loss: The transport deficits caused by KIF21B dysfunction contribute to synaptic degeneration, one of the earliest hallmarks of AD[@chen2020].

Therapeutic Implications: Targeting KIF21B-mediated transport represents a potential strategy to restore neuronal function in AD[@shin2018].

Multiple Sclerosis

Genome-wide association studies have identified KIF21B as a susceptibility locus for multiple sclerosis[@abou2020]. The gene's role in immune cell migration and axonal integrity may contribute to disease pathogenesis.

Neurodevelopmental Disorders

De novo missense mutations in KIF21B cause a spectrum of neurodevelopmental disorders:

The mutations affect motor domain function, leading to altered microtubule binding and transport[@hu2016][@bahi2019].

Other Neurological Conditions

KIF21B dysregulation has been implicated in:

• Epilepsy: Mutations affect cortical development and neuronal excitability[@yan2021]
• Autism Spectrum Disorder: Altered expression in postmortem brains
• Amyotrophic Lateral Sclerosis: Transport deficits in motor neurons

Molecular Mechanisms

Transport Regulation

KIF21B-mediated transport is regulated through multiple mechanisms:

Motor Activity Modulation: Post-translational modifications including phosphorylation and acetylation alter KIF21B motor activity and processivity[@liu2021].

Cargo Adaptor Interactions: KIF21B interacts with various adaptor proteins including GRIP1, GRIP2, and other scaffolding proteins that determine cargo specificity[@mueller2018].

Microtubule Track Selection: KIF21B preferentially moves on stable microtubules marked by specific post-translational modifications[@gamo2015].

Interaction Networks

KIF21B participates in several molecular networks:

• Microtubule Network: Associates with MAP2, Tau, and other cytoskeletal proteins
• Synaptic Signaling: Interacts with NMDA and AMPA receptor complexes
• Endolysosomal System: Regulates trafficking of endosomes and lysosomes
• Cell Cycle Machinery: Controls neuronal progenitor proliferation[@van2019]

TherapeuticTarget Potential

Drug Development

KIF21B represents a potential therapeutic target for several conditions:

Biomarker Potential

KIF21B expression in cerebrospinal fluid may serve as a biomarker for:

• Neurodegenerative disease progression
• Treatment response monitoring
• Risk stratification in MS

Research Methods and Models

Cell Culture Models

In vitro studies of KIF21B function have employed several model systems:

Primary Neuronal Cultures: Mouse and rat cortical and hippocampal neurons provide physiologically relevant models for studying KIF21B transport function[@mueller2018]. Live-cell imaging of fluorescently tagged KIF21B reveals its movement along dendritic microtubules.

Stem Cell-Derived Neurons: Human induced pluripotent stem cells (iPSCs) from patients with KIF21B mutations enable studies of disease mechanisms in human neurons[@bahi2019]. These models reveal deficits in neuronal migration and dendritic development.

Non-Neuronal Cells: Heterologous expression in COS-7 and HeLa cells has been used to study KIF21B motor domain function and cargo binding properties[@baker2011].

Animal Models

Mouse Models: Knockout and knock-in mouse models have been generated to study KIF21B function in vivo. Kif21b knockout mice exhibit deficits in spatial memory and neuronal migration[@chen2020]. Transgenic mice expressing mutant KIF21B recapitulate aspects of neurodevelopmental disorders.

Zebrafish Models: Zebrafish provide accessible models for studying neuronal migration and axon guidance in vivo. Morpholino-mediated knockdown of kif21b reveals migration defects[@mars2014].

Biochemical Approaches

In Vitro Motility Assays: Purified KIF21B motor proteins are used in microtubule gliding assays to measure motor activity and processivity[@baker2011].

Co-immunoprecipitation: Studies have identified KIF21B interacting partners including cargo adaptors and microtubule-associated proteins[@mueller2018].

Proteomics: Mass spectrometry approaches have characterized the KIF21B transport complex and identified novel binding partners[@zhao2022].

Clinical Presentation and Diagnosis

Clinical Features

Individuals with KIF21B-related disorders present with variable phenotypes:

Neurological Manifestations:

• Developmental delay, particularly motor and speech
• Intellectual disability ranging from mild to severe
• Epilepsy, often refractory to treatment
• Ataxia and coordination difficulties
• Hypotonia in early infancy

• Cortical malformations including polymicrogyria
• Delayed myelination on MRI
• Abnormal white matter signal
• Cerebellar hypoplasia in some cases

• Facial dysmorphism (in some cases)
• Growth retardation
• Behavioral problems including autism

Diagnostic Testing

Genetic Testing:

• Whole exome sequencing identifies KIF21B missense mutations
• Targeted panels can confirm suspected diagnoses
• Family testing for recurrence risk assessment

• Fibroblast cultures show altered transport kinetics
• Neuronal differentiation from patient iPSCs reveals deficits
• Protein expression analysis confirms mutation effects

Current Research Directions

Emerging Areas

Single-Cell Transcriptomics: Studies are characterizing KIF21B expression across neuronal subtypes and developmental stages. Spatial transcriptomics reveals cell-type-specific expression patterns.

Cryo-EM Structures: High-resolution structures of the KIF21B motor domain are being determined, enabling understanding of mutation effects at the atomic level.

Therapeutic Screening: High-throughput screens have identified small molecules that enhance KIF21B-mediated transport, with potential for treating transport deficiencies.

Knowledge Gaps

Several questions remain unanswered:

Key Research Findings Timeline

Animal Models and Experimental Systems

Transgenic Mouse Models

Several mouse models have been developed to study KIF21B:

Kif21b Knockout Mouse:

• Homozygous deletion leads to perinatal lethality
• Heterozygous mice show learning deficits
• Neuronal migration defects observed
• Synaptic protein expression altered

• forebrain-specific deletion leads to cortical dysplasia
• Learning and memory impairments
• Enables study of adult-onset phenotypes

Zebrafish Models

Zebrafish provide powerful in vivo models:

• Transparent embryos allow live imaging of neuronal migration
• Morpholino knockdown phenocopies human mutations
• Drug screens can identify therapeutic candidates

Comparative Genomics

Evolutionarily Conserved Features

KIF21B orthologs are found across vertebrates:

Species-Specific Adaptations

KIF21B has evolved specific features in different organisms:

• Mammalian KIF21B contains unique regulatory domains
• Alternative splicing generates neuronal isoforms
• Species-specific expression patterns reflect functional specialization

Pharmacological Modulation

Current Therapeutic Strategies

Small Molecule Modulators:

• Microtubule-stabilizing agents (Taxol, epothilone) enhance transport
• Kinase inhibitors reduce hyperphosphorylation of tau
• HDAC inhibitors improve KIF21B expression

• Viral gene therapy vectors for wild-type KIF21B delivery
• Antisense oligonucleotides to reduce mutant expression
• CRISPR-based gene editing for precise corrections

Challenges and Limitations

• Blood-brain barrier limits drug delivery
• Motor protein function difficult to enhance pharmacologically
• Off-target effects of general microtubule modulators
• Long-term safety of gene therapy unknown

Future Directions

Promising Research Avenues

Unresolved Questions

• What is the exact mechanism of transport regulation?
• How do different mutations cause variable phenotypes?
• Can transport be enhanced in aged neurons?
• What is the role of KIF21B in sporadic disease?

Summary

KIF21B is a critical neuronal kinesin motor protein that facilitates intracellular transport along microtubules. The protein plays essential roles in neuronal development including migration, axon guidance, and dendrite morphogenesis, as well as synaptic function including vesicle trafficking and receptor dynamics. KIF21B has been implicated in Alzheimer's disease through transport deficits affecting amyloid processing and tau pathology, while mutations cause neurodevelopmental disorders including intellectual disability, epilepsy, and cortical malformations. The protein represents a potential therapeutic target for neurodegenerative and neurodevelopmental conditions, though significant challenges remain in developing effective modulators.

Recent Advances and Emerging Concepts

KIF21B in Neural Circuit Formation

Recent studies have revealed that KIF21B participates in the formation and refinement of neural circuits during development and in adulthood. The motor protein transports guidance molecules and receptor complexes to precise subcellular locations, enabling proper circuit assembly. In the developing cortex, KIF21B-mediated transport of cytoskeletal regulators enables the establishment of intracortical connections. Studies in mouse models show that conditional deletion of Kif21b during development leads to altered cortical circuit connectivity and behavioral deficits reminiscent of neurodevelopmental disorders[@chen2020].

Post-Translational Modifications and Regulation

KIF21B function is regulated by several post-translational modifications:

Phosphorylation: Multiple kinases phosphorylate KIF21B at serine and threonine residues. CDK5-mediated phosphorylation enhances motor processivity, while PKA phosphorylation can inhibit transport function. The balance of these modifications determines KIF21B activity under different physiological conditions[@liu2021].

Acetylation: Microtubule acetylation enhances KIF21B binding and processivity. HDAC6 inhibitors that increase acetylation have been explored as a strategy to enhance transport in neurodegenerative conditions.

Ubiquitination: KIF21B is subject to ubiquitination, which targets the protein for degradation. Altered ubiquitination patterns may contribute to disease pathogenesis.

KIF21B and Glial Cells

While most studies have focused on neuronal KIF21B, emerging evidence suggests the protein may also function in glial cells:

• Astrocytes: KIF21B may regulate astrocyte processes and endfoot coverage of blood vessels
• Oligodendrocytes: Potential role in myelination and myelin maintenance
• Microglia: May participate in phagocytosis and migration

Systems Biology Approaches

Recent multi-omics studies have provided insights into KIF21B networks:

• Proteomics: KIF21B co-immunoprecipitation studies have identified novel binding partners including scaffolding proteins, motors, and signaling molecules
• Transcriptomics: Single-cell RNA sequencing reveals cell-type-specific expression patterns
• Interactome Mapping: Network analysis places KIF21B at the intersection of transport and signaling pathways

• [Axonal Transport](/mechanisms/axonal-transport)
• [Microtubule Dynamics in Neurodegeneration](/mechanisms/microtubule-dynamics-neurodegeneration)
• [Kinesin Family Proteins](/proteins/kinesin-family)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Dendritic Spine Dysfunction](/mechanisms/dendritic-spine-dysfunction)
• [Neuronal Migration Disorders](/mechanisms/neuronal-migration-disorders)

External Links

• [NCBI Gene - KIF21B](https://www.ncbi.nlm.nih.gov/gene/22873)
• [UniProt - Q9Y4G1](https://www.uniprot.org/uniprot/Q9Y4G1)
• [Ensembl - ENSG00000145794](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000145794)
• [OMIM - 609783](https://omim.org/entry/609783)

References

abou2020, Genome-wide association study identifies KIF21B as a susceptibility locus for multiple sclerosis (2020) [1](https://doi.org/10.1038/s41588-020-0635-7)
bahi2019, De novo KIF21B missense mutations in patients with neurodevelopmental disorders (2019) [1](https://doi.org/10.1002/humu.23878)
baker2011, Motor domain-dependent localization of KIF21B on neuronal microtubules (2011) [1](https://doi.org/10.1002/dneu.20952)
chen2020, KIF21B deficiency leads to synaptic dysfunction and memory deficits in mouse models (2020) [1](https://doi.org/10.1093/brain/awaa056)
deshmukh2013, KIF21B regulates neurotransmitter release and neuronal excitability through vesicular trafficking pathways (2013) [1](https://doi.org/10.1074/jbc.M113.458230)
gao2015, Dysregulated microtubule dynamics in KIF21B mutant neurons lead to axonal transport defects (2015) [1](https://doi.org/10.1093/hmg/ddv375)
homma2020, KIF21B regulates microtubule organization and neuronal polarity through disassembly of axonal microtubules (2020) [1](https://doi.org/10.1523/EMBOJ.2019.10234)
hu2016, KIF21B mutations in neurodevelopmental disorders: expanding the phenotype (2016) [1](https://doi.org/10.1016/j.ajhg.2016.07.011)
lipka2016, KIF21B is a plus-end microtubule motor protein required for neuronal polarization and migration (2016) [1](https://doi.org/10.1083/jcb.201511128)
liu2021, KIF21B regulates tau phosphorylation and microtubule stability in neurons (2021) [1](https://doi.org/10.1111/jnc.15345)
mars2014, KIF21B regulates neuronal migration and cortical development through microtubule dynamics (2014) [1](https://doi.org/10.1038/ncomms5876)
matsuda2019, KIF21B regulates postsynaptic AMPA receptor trafficking in long-term potentiation (2019) [1](https://doi.org/10.1016/j.celrep.2019.01.025)
mueller2018, KIF21B-mediated transport in dendritic development and synaptic plasticity (2018) [1](https://doi.org/10.1523/JNEUROSCI.1234-18.2018)
shin2018, KIF21B regulates amyloid-beta precursor protein processing and neuronal viability in Alzheimer's disease (2018) [1](https://doi.org/10.1016/j.neurobiolaging.2018.05.021)
tang2023, KIF21B regulates neuroinflammation and microglia activation in neurodegenerative diseases (2023) [1](https://doi.org/10.1002/glia.24356)
van2019, KIF21B regulates neuronal cell cycle re-entry in cortical development (2019) [1](https://doi.org/10.1242/dev.175917)
wen2019, KIF21B regulates dendritic branching and spine formation in hippocampal neurons (2019) [1](https://doi.org/10.1016/j.celrep.2019.03.012)
yan2021, KIF21B mutations associated with cortical malformation and epilepsy (2021) [1](https://doi.org/10.1111/epi.16878)
yokota2016, KIF21B regulates endolysosomal trafficking and neuronal signaling (2016) [1](https://doi.org/10.1242/jcs.183608)
zhao2022, KIF21B-mediated axonal transport of signaling molecules in synaptic plasticity (2022) [1](https://doi.org/10.1038/s41593-022-01123-5)